Reference intervals for brain natriuretic peptide in healthy newborns and infants measured with an automated immunoassay platform

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 5, 2010, Pages 697-700

  Cantinotti, Massimiliano ^a   Storti, Simona ^a   Parri, Maria Serena ^a   Prontera, Concetta ^a   Murzi, Bruno ^a   Clerico, Aldo ^a  

^a SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

B type natriuretic hormone; Infants; Natriuretic peptides; Newborns; Reference values

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ARTICLE; AUTOANALYZER; CHILD; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; INFANT; MALE; NEWBORN; NORMAL HUMAN; PLASMA; PRESCHOOL CHILD; PRIORITY JOURNAL; REFERENCE VALUE; SCHOOL CHILD;

AUTOMATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOASSAY; INFANT; INFANT, NEWBORN; MALE; NATRIURETIC PEPTIDE, BRAIN; REFERENCE VALUES;

EID: 77952498617     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.129     Document Type: Article

References (19)

1. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Poni-kowski P, Poole-Wilson PA, et al. Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29:2388-442.
2. Clerico A, Emdin M. Diagnostic accuracy and prognostic relevance of the measurement of the cardiac natriuretic peptides: a review. Clin Chem 2004;50:33-50.
3. Doust JA, Glasziou PP, Pietrzak E, Dobson AJ. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med 2004;164:1978-84.
4. Mant J, Doust J, Roalfe A, Barton P, Cowie MR, Glasziou P, et al. Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. Health Techno Assess 2009;13:1-207.
5. Cantinotti M, Clerico A, Murzi M, Vittorini S, Emdin M. Clinical relevance of measurement of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in pediatric cardiology. Clin Chim Acta 2008;390:12-22.
6. Nir A, Lindinger A, Rauh M, Bar-Oz B, Laer S, Schwachtgen L, et al. NT-Pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies. Pediatr Cardiol 2009;30:3-8.
7. Favilli S, Frenos S, Lasagni D, Frenos F, Pollini I, Bernini G, et al. The use of B-type natriuretic peptide in paediatric patients: a review of literature. J Cardiovasc Med 2009;10:298-302.
8. Apple FS, Panteghini M, Ravkilde J, Mair J, Wu AH, Tate J, et al. On behalf of the Committee on Standardization of Markers of Cardiac Damage of the IFCC. Quality specifications for B-type natriuretic peptide assays. Clin Chem 2005;51:486-93.
9. Apple FS, Wu AH, Jaffe AS, Panteghini M, Christenson RH, Cannon CP, et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: analytical issues for biomarkers of heart failure. Circulation 2007;116: e95-8. (Pubitemid 47450267)
10. Clerico A, Recchia FA, Passino C, Emdin M. Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications. Am J Physiol Heart Circ Physiol 2006;290: H17-29.
11. Prontera C, Zaninotto M, Giovannini S, Zucchelli GC, Pilo A, Sciacovelli L, et al. Proficiency testing project for brain natriu-retic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmocheck study. Clin Chem Lab Med 2009;47:762-8.
12. Soldin SJ, Soldin OP, Boyajian AJ, Taskier MS. Pediatric brain natriuretic peptide and N-terminal pro-brain natriuretic peptide reference intervals. Clin Chim Acta 2006;366:304-8.
13. Cantinotti M, Storti S, Parri MS, Murzi M, Clerico A. Reference values for plasma B-type natriuretic peptide in the first days of life. Clin Chem 2009;55:1438-40.
14. Prontera C, Storti S, Emdin M, Passino C, Zyw L, Zucchelli GC, et al. Comparison of a fully automated immunoassay with a point-of-care testing method for B-type natriuretic peptide. Clin Chem 2005;51:1274-6.
15. Cleveland WS. LOWESS: a program for smoothing scatterplots by robust locally weighted regression. Am Statistician 1981;35:54.
16. Clerico A, Fontana M, Vittorini S, Emdin M. The search for a pathophysiological link between gender, cardiac endocrine function, body mass regulation and cardiac mortality: proposal for a working hypothesis. Clin Chim Acta 2009;405:1-7.
17. Mansoub S, Chan MK, Adeli K. Gap analysis of pediatric reference intervals for risk biomarkers of cardiovascular disease and the metabolic syndrome. Clin Biochem 2006;39:569-87.
18. Mir TS, Laux R, Hellwege HH, Liedke B, Heinze C, von Buelow H, et al. Plasma concentrations of aminoterminal pro atrial natriuretic peptide and aminoterminal pro brain natriuretic pep-tide in healthy neonates: marked and rapid increase after birth. Pediatrics 2003;112:896-9.
19. Clinical and Laboratory Standards Institute. Defining, establishing, and verifying reference intervals in the clinical laboratory; proposed guideline. 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute, 2008. CLSI document C28-P3.